Navigation Links
ThromboGenics Announces Promising Results of MITI IV Phase II Trial in the Treatment of Acute Stroke with Microplasmin
Date:9/28/2008

or ThromboGenics' shareholders."

About ThromboGenics

ThromboGenics is a biotechnology company focused on the discovery and development of biopharmaceuticals for the treatment of eye disease, vascular disease and cancer. The Company has several programs in Phase II clinical development including microplasmin, which is being evaluated as a treatment for vitreoretinal disorders and as a thrombolytic agent for vascular occlusive diseases. ThromboGenics is also developing novel antibody therapeutics in collaboration with BioInvent International; these include TB-402 (Anti-Factor VIII), a long acting anti-coagulant, and TB-403 for cancer.

ThromboGenics has built strong links with the University of Leuven and the Flanders Institute for Biotechnology (VIB) and has exclusive rights to certain therapeutics developed at these institutions. ThromboGenics is headquartered in Leuven, Belgium and has subsidiaries in Dublin, Ireland and New York, U.S. The Company is listed on Eurolist by Euronext Brussels under the symbol THR. More information is available at http://www.thrombogenics.com.

Important information about forward-looking statements

Certain statements in this press release may be considered "forward-looking". Such forward-looking statements are based on current expectations, and, accordingly, entail and are influenced by various risks and uncertainties. The Company therefore cannot provide any assurance that such forward-looking statements will materialize and does not assume an obligation to update or revise any forward-looking statement, whether as a result of new information, future events or any other reason. Additional information concerning risks and uncertainties affecting the business and other factors that could cause actual results to differ materially from any forward-looking statement is contained in the Company's Annual Report.

For further information ple
'/>"/>

SOURCE ThromboGenics NV
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ThromboGenics Completes Patient Enrolment in the Phase IIb Trial of Microplasmin in Vitrectomy (MIVI III)
2. Indevus Announces Agreement With Teva to Develop Pagoclone for the Treatment of Stuttering
3. Clinton Global Initiative Announces BDs Commitment to Biamba Marie Mutombo Hospital
4. Quark Pharmaceuticals Announces First RNAi Drug Candidate Having a Novel, Proprietary Structure Covered by Quark Intellectual Property
5. Chemstar Corporation Announces a New Powerful, One-Step Product That Effectively Controls Listeria, Salmonella, E. coli and Fly Larvae in Floor Drains
6. QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy
7. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
8. Phosphagenics Announces Initiation of Phase 1 Clinical Trial in Humans for Its Transdermal Lidocaine
9. Napo Announces Positive Clinical Data Indicating Crofelemer, Could Effectively Treat Cholera
10. Encorium Announces the Initiation of a Strategic Partnership With Prologue Research After the Postponement of Negotiations Regarding Its Planned Acquisition; Strategic Reorganization and Cost Reduction Plan Initiated as Strategic Alternatives are Investig
11. PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) Needle
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... Salix Pharmaceuticals, Ltd. (the " Company " ... Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) (TSX:VRX), ... Fundamental Changes, Make-Whole Fundamental Changes and Merger Event, Fundamental ... and Offer to Purchase (the " Notice ") to ... (the " Notes "), pursuant to the Indenture, dated ...
(Date:4/1/2015)... , April 1, 2015  Hologic, Inc. (NASDAQ: ... holders of the 2.00% Convertible Exchange Senior Notes due ... and Wilmington Trust Company, the trustee, paying agent and ... to convert the notes.  This conversion right is subject ... notes dated as of December 10, 2007, as supplemented ...
(Date:4/1/2015)... ATLANTA , April 1, 2015  The ... medication, and dietary supplements to treat attention-deficit/hyperactivity disorder ... than one half of children with ADHD were ... Centers for Disease Control and Prevention (CDC) study, ... Health Care Needs," published today in The ...
Breaking Medicine Technology:Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 2Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 3Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 4Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 5Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 6Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 7Hologic Delivers Notice that Holders of 2.00% Convertible Exchange Senior Notes Due 2037 are Eligible to Convert 2CDC publishes first national study on use of behavioral therapy, medication and dietary supplements for ADHD in children 2CDC publishes first national study on use of behavioral therapy, medication and dietary supplements for ADHD in children 3CDC publishes first national study on use of behavioral therapy, medication and dietary supplements for ADHD in children 4
... IRIDEX Corporation (Nasdaq: IRIX ) today announced ... the ROTH 23rd Annual OC Growth Stock Conference on Monday, ... being held March 13-16 at the Ritz Carlton Laguna Niguel ... accessible by live webcast on the Investor section of IRIDEX,s ...
... 2011 To help reduce state Medicaid spending, the ... in charge of the state,s Medicaid program, has proposed ... like those in the private sector that are more ... would save state taxpayers $82 million.  Governors Chris Christie ...
Cached Medicine Technology:Texas Health and Human Services Commission: Modernize Medicaid Pharmacy to Save State $82 Million 2
(Date:4/2/2015)... 2015 Veale Outdoor Advertising, the Northern ... billboards to its name, announces its digital display in ... area. Similar to the first 14-by-48 foot digital ... California, the addition means, in total, the Network reaches ... after tourist population traveling through the San Francisco, Sonoma, ...
(Date:4/2/2015)... (PRWEB) April 02, 2015 Steviva ... and custom sweetening solutions, recently announced the rebranding ... are Erysweet+ with stevia and Erysweet+ 100 mesh ... Stevia Blend fine powder, respectively. , Erysweet+ with ... and naturally fermented erythritol. It delivers a natural ...
(Date:4/2/2015)... Atlanta-based Kanga, the first SaaS-based platform for management ... Up in Atlanta by General Assembly Atlanta. Six companies ... LOV, Ticket Alternative, and TripTap. T General Assembly presented ... 500 at their Atlanta Launch Party at Ponce City ... platform for initiating, managing and tracking last mile deliveries ...
(Date:4/1/2015)... (PRWEB) April 02, 2015 Robins & ... Southern Living Media Services Building for the New T-Mobile ... just five months, including complete demolition of the interior ... the addition of 250 parking spaces to accommodate employees. ... says his firm was excited to develop such a ...
(Date:4/1/2015)... 2015 Glen Mills, PA - Holganix ... Farm’s, Healthy Grow fertilizer line to produce an organic-based ... Holganix manufactures a line of organic bionutritional products that ... optimal plant, turf and tree health. Pearl Valley Farms ... and a manufacturer of organic fertilizers. , Healthy ...
Breaking Medicine News(10 mins):Health News:Veale Outdoor Advertising State of the Art Digital Billboards Reach 12 Million in SF Bay Area 2Health News:Steviva Ingredients Announces Erysweet+ Rebrand 2Health News:Kanga Wins Best Start Up in Atlanta 2Health News:Robins & Morton Transforms Former Southern Living Media Services Building for New T-Mobile Financial Care Call Center 2Health News:Holganix Expands Its Organic Turf Portfolio Success by Partnering with Pearl Valley Farms to Produce an Organic-Based Granular Fertilizer 2
... about the fifty states--from Spanish speakers to strawberries produced to Bigfoot ... ... Washington, DC (PRWEB) February 4, 2009 -- SHOW®USA, a website with ... the fifty states in a whole new way, launched today. , ...
... The economic cost of methamphetamine use in the United ... of addiction, premature death, drug treatment and many other ... Corporation study. , The RAND study is the first ... costs of the methamphetamine problem in the United States. ...
... Previously Issued Recall to Wholesale Level on Certain Products Expanded ... subsidiary of KV Pharmaceutical Company (NYSE: KVa ... level of a previously announced recall on certain products. ... issued to the wholesale level, but is now being expanded ...
... Feb. 3 Companies that manufacture products containing ... product stewardship measures to limit potential liability exposure ... Klapper and James Wood.This issue will be thoroughly ... Law, Regulation and Policy, February 18-19, 2009, in ...
... involved in cell migration, is associated with liver cancer ... be used as a biomarker for diagnosis and a ... issue of Hepatology , a journal published by ... Association for the Study of Liver Diseases (AASLD). The ...
... lives of one million families by offering an economic ... Shaklee Corporation Chairman and CEO Roger Barnett will ... offers economic support to one million families in 2009. ... Greensboro, NC. "Families are struggling to make ends ...
Cached Medicine News:Health News:SHOWUSA Launches: New Website Showcases Animated Maps of U.S. Facts and Figures 2Health News:Methamphetamine use cost the US about $23 billion in 2005, RAND study estimates 2Health News:Methamphetamine use cost the US about $23 billion in 2005, RAND study estimates 3Health News:ETHEX Corporation Issues Voluntary Nationwide Recall 2Health News:Risk-Management Policies Needed Now in Nanotechnology, Insighter Piece Concludes; FDLI Sponsors Nanotechnology Meeting, Publishes Book on FDA-Regulated Products 2Health News:Protein predicts liver cancer recurrence and after transplantation 2Health News:Shaklee Hits the Road With Its Infinite Possibilities Tour 2
... kit features a patented Per-fit™ flexible PVC ... a low-profile cuff specifically designed to reduce ... the patients anatomy. The kit s unique ... tube snugly, allowing for an easier transition ...
... Self-contained kits provide convenience and cost control. ... care trays offer a variety of wound ... management of the tracheostomized patient. , ... and trays with disposable inner cannula for ...
Disposable tracheostomy care tray....
... Medline Has the Right Solution For ... tracheostomy clean and care tray features the ... of this important infection control task. Designed ... the individual needs of each patient and ...
Medicine Products: